The researchers sorted patients who discontinued their obesity medications into two groups: those who did it within just three months and by three months to a year
Neurobiol Dis 55:2635
Correct site rotation, calm injection technique, and proper storage all support safe, comfortable treatment
Retatrutide activates GLP-1 receptors (insulin secretion, appetite suppression), GIP receptors (insulin secretion, adipose tissue modulation), and glucagon receptors (increased energy expenditure, hepatic glucose regulation) concurrently
1 Dose schedule used in the trials The trials used a 16-week build-up to the full dose, increasing from 0.25 mg to 2.4 mg every 4 weeks, the same schedule used for Wegovy
The Southend Pharmacy connection Understanding Brello Health requires understanding who actually makes the medication